Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 3
2015 1
2017 2
2019 1
2020 2
2021 6
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Screening and Validation of Molecular Targeted Radiosensitizers.
Willers H, Pan X, Borgeaud N, Korovina I, Koi L, Egan R, Greninger P, Rosenkranz A, Kung J, Liss AS, Parsels LA, Morgan MA, Lawrence TS, Lin SH, Hong TS, Yeap BY, Wirth LJ, Hata AN, Ott CJ, Benes CH, Baumann M, Krause M. Willers H, et al. Among authors: koi l. Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):e63-e74. doi: 10.1016/j.ijrobp.2021.07.1694. Epub 2021 Jul 31. Int J Radiat Oncol Biol Phys. 2021. PMID: 34343607 Free PMC article.
Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial.
Dietrich A, Andreeff M, Koi L, Bergmann R, Schubert M, Schreiner L, Löck S, Sihver W, Freudenberg R, Hering S, Pietzsch HJ, Steinbach J, Kotzerke J, Baumann M, Krause M. Dietrich A, et al. Among authors: koi l. Radiother Oncol. 2021 Feb;155:285-292. doi: 10.1016/j.radonc.2020.11.013. Epub 2020 Nov 21. Radiother Oncol. 2021. PMID: 33227356 Free article.
In reply to the Letter to the Editor by Chen and Lui regarding "Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial" by A Dietrich et al.
Dietrich A, Andreeff M, Koi L, Bergmann R, Schubert M, Schreiner L, Löck S, Sihver W, Freudenberg R, Hering S, Pietzsch HJ, Steinbach J, Kotzerke J, Baumann M, Krause M. Dietrich A, et al. Among authors: koi l. Radiother Oncol. 2021 Aug;161:261-262. doi: 10.1016/j.radonc.2021.06.014. Epub 2021 Jun 11. Radiother Oncol. 2021. PMID: 34119587 No abstract available.
Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial.
Hölscher T, Baumann M, Kotzerke J, Zöphel K, Paulsen F, Müller AC, Zips D, Koi L, Thomas C, Löck S, Krause M, Wirth M, Lohaus F. Hölscher T, et al. Among authors: koi l. Eur Urol Oncol. 2022 Feb;5(1):44-51. doi: 10.1016/j.euo.2021.10.002. Epub 2021 Nov 14. Eur Urol Oncol. 2022. PMID: 34785189 Free article. Clinical Trial.
Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC).
Rassamegevanon T, Feindt L, Koi L, Müller J, Freudenberg R, Löck S, Sihver W, Çevik E, Kühn AC, von Neubeck C, Linge A, Pietzsch HJ, Kotzerke J, Baumann M, Krause M, Dietrich A. Rassamegevanon T, et al. Among authors: koi l. Cancers (Basel). 2021 Nov 9;13(22):5595. doi: 10.3390/cancers13225595. Cancers (Basel). 2021. PMID: 34830750 Free PMC article.
Preclinical trial comparing radiotherapy alone versus standard radiochemotherapy in three human papilloma virus (HPV) negative and three HPV-positive head and neck squamous cell carcinoma (HNSCC) xenograft tumour models.
Valentini C, Ebert N, Koi L, Pfeifer M, Löck S, Erdmann C, Krause M, Baumann M. Valentini C, et al. Among authors: koi l. Radiother Oncol. 2023 Jun;183:109546. doi: 10.1016/j.radonc.2023.109546. Epub 2023 Feb 20. Radiother Oncol. 2023. PMID: 36813172 Clinical Trial.
16 results